Ebos Group (ASX:EBO) EBIT : A$452 Mil (TTM As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is Ebos Group EBIT?

Ebos Group's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2023 was A$233 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2023 was A$452 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Ebos Group's annualized ROC % for the quarter that ended in Dec. 2023 was 8.57%. Ebos Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 46.67%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Ebos Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 6.06%.

Ebos Group EBIT Historical Data

The historical data trend for Ebos Group's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group EBIT Chart

Ebos Group Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

EBIT

Get a 7-Day Free Trial

219.05

253.70

283.34

318.96

438.94

Ebos Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBIT	Get a 7-Day Free Trial															159.20	167.21	226.92	218.64	233.32

Competitive Comparison of Ebos Group's EBIT

For the Medical Distribution subindustry, Ebos Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Ebos Group's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Ebos Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Ebos Group's EV-to-EBIT falls into.

Ebos Group EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$452 Mil.

Ebos Group (ASX:EBO) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Ebos Group's annualized ROC % for the quarter that ended in Dec. 2023 is calculated as:

	ROC % (Q: Dec. 2023 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2023 )	+	Invested Capital (Q: Dec. 2023 ))	/ count )
=	487.174 * ( 1 - 28.5% )	/	( (3890.392	+	4234.496)	/ 2 )
=	348.32941	/	4062.444
=	8.57 %

where

	Invested Capital		(Q: Jun. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	6403.482	-	2302.308	-	( 210.782	-	max(0, 2644.199	-	2991.204	+	210.782	))
=	3890.392

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	6943.059	-	2342.863	-	( 365.7	-	max(0, 2655.718	-	3289.758	+	365.7	))
=	4234.496

Note: The Operating Income data used here is two times the semi-annual (Dec. 2023) data.

2. Joel Greenblatt's definition of Return on Capital:

Ebos Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2023 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2023		Q: Dec. 2023
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	466.644	/	( ( (657.232 + max(145.572, 0))	+	(700.702 + max(496.14, 0)) )	/	2 )
=	466.644	/	( ( 802.804	+	1196.842 )	/	2 )
=	466.644	/	999.823
=	46.67 %

where Working Capital is:

	Working Capital		(Q: Jun. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1407.284	+	1227.804	+	62.898)	-	(2302.308	+	6.337	+	243.769)
=	145.572

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1528.701	+	1335.69	+	59.667)	-	(2342.863	+	14.228	+	70.827)
=	496.14

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2023) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Ebos Group's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2023 )
	=	451.958	/	7456.601
	=	6.06 %

Ebos Group EBIT Related Terms

Thank you for viewing the detailed overview of Ebos Group's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Ebos Group (ASX:EBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (ASX:EBO) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

EBO:New Zealand EJG:Germany

Address

108 Wrights Road, P.O. Box 411, Christchurch, STL, NZL, 8024

Website

https://www.ebosgroup.com

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low single digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group (ASX:EBO) Headlines

No Headlines